Newborn Screening for Cystic Fibrosis in Genetically Heterogeneous Populations
Received Date: Apr 13, 2021 / Accepted Date: Apr 27, 2021 / Published Date: May 04, 2021
Abstract
Cystic fibrosis is the most frequent autosomal recessive disease in Caucasians. Survival improves with the implementation of newborn screening programs that enable early detection and rapid initiation of treatment to reduce the effects of the disease. Not all available algorithms for newborn screening are suitable for all populations. IRT/PAP is the algorithm of choice in genetically heterogeneous populations.
Keywords: Cystic fibrosis; Newborn screening; Immunoreactive trypsinogen; Pancreatitis-associated protein
Citation: Teper A, Rodríguez V (2021) Newborn Screening for Cystic Fibrosis in Genetically Heterogeneous Populations. Neonat Pediatr Med7:212. Doi: 10.4172/2572-4983.1000212
Copyright: © 2021 Teper A, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Conferences
7th International Conference on Anti-Cancer Drugs & Therapies
Vancouver, Canada
9th World Conference on Nursing Education & Nursing Practice
Toronto, Canada
42nd Global Conference on Nursing Care & Patient Safety
Toronto, CanadaRecommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 1812
- [From(publication date): 0-2021 - Nov 24, 2024]
- Breakdown by view type
- HTML page views: 1249
- PDF downloads: 563
